Brief: Oxigene announces name change to Mateon Therapeutics
17/06/2016 15:15
June 17 (Reuters) - Oxigene Inc OXGN.O :
* Oxigene announces name change to Mateon Therapeutics
* Announced that it has changed its name to Mateon
Therapeutics, Inc., effective immediately
* Shares of Mateon's common stock will begin trading under
new ticker symbol "MATN"
Source text for Eikon: ID:nGNXMWJLAa
Further company coverage: OXGN.O
((Bengaluru Newsroom: +1 646 223 8780))
Recent news on Oncotelic Therapeutics
See all newsBrief: Oncotelic Therapeutics Emerging As Leader With New Independent JV Valuation
Brief: Oncotelic Therapeutics - JV Is Preparing For A Potential Initial Public Offering On The Hong Kong Stock Exchange In Late 2026
Brief: Oncotelic Therapeutics To Sell Its Necroptosis Cancer Therapy Assets To Mosaic Immunoengineering
Brief: Oncotelic Announces Initiation Of Clinical Study In Non-Small Lung Cell Cancer
Brief: Oncotelic Initiates Clinical Trials Evaluating Ot-101 Against Pediatric Gliomas